Nicole joined HTANALYSTS as an Intern in Aug 2024 and progressed to a consultant in Feb 2025. Nicole has contributed to a range of health technology assessment including PBAC and MSAC submissions, feasibility assessments across multiple clinical indications, and broader value work such as impact assessments and social return on investments.  

Nicole’s project experience includes PBAC submission work across neurological and respiratory conditions, as well as patient engagement and advisory boards. She has also led impact assessments relating to genetic technologies and contributed to the development of clinical guidelines and Social Return on Investment assessments.

Before joining HTANALYSTS, Nicole worked in clinical research and strategy consulting. She holds a Bachelor of Biomedical Science from the University of Queensland and a Master of Public Health from the University of Sydney. She is also certified as a Social Return on Investment Level I practitioner.